Home
About
Overview
Sharing Data
ORCID
Help
History (12)
Design and methods for testing a simple dietary message to improve weight loss and dietary quality.
Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1.
Renewable Energy
Sodium Iodide
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
See All 12 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel drug combinations for the management of relapsed/refractory multiple myeloma.
Usmani SZ, Lonial S. Novel drug combinations for the management of relapsed/refractory multiple myeloma. Clin Lymphoma Myeloma Leuk. 2014 Sep; 14 Suppl:S71-7.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antineoplastic Combined Chemotherapy Protocols
Disease Management
Disease Progression
Histone Deacetylase Inhibitors
Humans
Multiple Myeloma
Oligopeptides
Proteasome Inhibitors
Recurrence
Thalidomide
authors with profiles
Saad Usmani MD